drugset / Trial / NCT02588716

Effects of Terlipressin on Blood Loss and Transfusion Requirements During Major Liver Resection.

NCT02588716

Phase 2 Completed 84 enrolled Assiut University
RandomizedParallel-groupDouble-blindPrevention

Summary

To evaluate the effects of Terlipressin infusion on blood loss \& transfusion requirements in cirrhotic patients undergoing major liver resections.

Timeline

Start
2015-09
Primary completion
2016-03
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Terlipressin Peptide 2 ug/kg Intravenous

Indications